Supplementary Data S2 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial Article Swipe
Related Concepts
Zoledronic acid
Ewing's sarcoma
Sarcoma
Medicine
Oncology
Internal medicine
Pathology
Raphael Koch
,
Lianne Haveman
,
Ruth Ladenstein
,
Bénédicte Brichard
,
Heribert Jürgens
,
Soňa Cyprová
,
Henk van den Berg
,
Wolf Hassenpflug
,
Anna Raciborska
,
Torben Ek
,
Daniel Baumhoer
,
Gerlinde Egerer
,
Leo Kager
,
Marleen Renard
,
Péter Hauser
,
Stefan Burdach
,
Judith V.M.G. Bovée
,
Angela Hong
,
Peter Reichardt
,
Jarmila Kruseová
,
Arne Streitbürger
,
Thomas Kühne
,
Torsten Keßler
,
Marie Bernkopf
,
Trude Butterfaß‐Bahloul
,
Catharina Dhooge
,
Sebastian Bauer
,
János Kiss
,
Michael Paulussen
,
Fiona Bonar
,
Andreas Ranft
,
Beate Timmermann
,
Jelena Rascon
,
Volker Vieth
,
Jukka Kanerva
,
Andreas Faldum
,
Wolfgang Hartmann
,
Lars Hjorth
,
Vivek A. Bhadri
,
Markus Metzler
,
Hans Gelderblom
,
Uta Dirksen
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24825969
· OA: W4389792485
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24825969
· OA: W4389792485
<p>Criteria for the definition of the per protocol set</p>
Related Topics
Finding more related topics…